Position in ABBV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,289,318
-$195,611 QoQ
Shares Held
15,124
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GAMCO INVESTORS, INC. ET AL holds $78,759,412 across 8 Drug Manufacturers - General names. ABBV ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,339 | $24,225,822 | |
| 2 | JNJ |
Johnson & Johnson
|
80,414 | $19,656,398 | |
| 3 | PFE |
Pfizer Inc
|
589,634 | $16,556,922 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,769 | $7,791,063 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
87,058 | $5,280,067 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
15,124 | $3,289,318 | |
| 7 | AMGN |
Amgen Inc
|
5,023 | $1,767,342 | |
| 8 | GRFS |
Grifols SA
|
24,000 | $192,480 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,289,318 | 15,124 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,484,929 | 15,252 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,535,152 | 15,268 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,923,515 | 15,750 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,796,672 | 13,348 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,405,524 | 13,537 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,688,295 | 13,613 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,530,091 | 14,751 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,599,659 | 14,276 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,360,348 | 15,231 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,422,970 | 16,255 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,192,057 | 16,270 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,094,487 | 19,417 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,245,452 | 20,082 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,628,368 | 19,584 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,793,944 | 18,242 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,104,892 | 19,153 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $2,821,194 | 20,836 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,669,998 | 24,752 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,436,403 | 21,630 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,333,547 | 21,563 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,223,362 | 20,750 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,438,943 | 27,845 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,949,683 | 40,229 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,348,785 | 30,828 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||